

Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and upcoming biotech presentation plans.
You can purchase shares of Azitra (AMEX:AZTR) through any online brokerage.
Other companies in Azitra’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Azitra has a consensus price target of $40.00.
The stock price for Azitra (AMEX: AZTR) is $0.6099 last updated November 11, 2026 at 1:05 PM EST.
There are no upcoming dividends for Azitra.
Azitra does not have any upcoming earnings scheduled.
There is no upcoming split for Azitra.
Azitra is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial...